SCHEMBL21047355

SCHEMBL21047355

Cc1ccc(S(=O)(=O)n2cnc(/C=N/[S+]([O-])C(C)(C)C)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.44
MAPT P10636 3/20 0.42
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 4/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
TP53 P04637 1/20 0.37
KDM4E B2RXH2 1/20 0.36
PKM P14618 1/20 0.36
ALDH3A1 P30838 2/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
NOD1 Q9Y239 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 3/20 0.33
HPGD P15428 1/20 0.33
GRM4 Q14833 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MAPK10 P53779 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21047358 1.00 GAA (0.44) GAAMAPTKMT2AALDH1A1CA1
SCHEMBL21047356 1.00 GAA (0.44) GAAMAPTKMT2AALDH1A1CA1
SCHEMBL21047287 0.79 ALDH1A1 (0.41) MAPTKMT2AALDH1A1CA1CA2
SCHEMBL19859803 0.79 ALDH1A1 (0.41) MAPTKMT2AALDH1A1CA1CA2
SCHEMBL21047285 0.79 ALDH1A1 (0.41) MAPTKMT2AALDH1A1CA1CA2
SCHEMBL21047286 0.79 ALDH1A1 (0.41) MAPTKMT2AALDH1A1CA1CA2
SCHEMBL23781232 0.77 ALDH1A1 (0.47) MAPTKMT2AALDH1A1CA1CA2
SCHEMBL23781231 0.77 ALDH1A1 (0.47) MAPTKMT2AALDH1A1CA1CA2
SCHEMBL23781233 0.77 ALDH1A1 (0.47) MAPTKMT2AALDH1A1CA1CA2
SCHEMBL6771462 0.76 GAA (0.55) GAAMAPTKMT2AALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190169181-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN, INC. 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169181-A1 FUMAGILLOL COMPOUNDS AND METHODS OF MAKING AND USING SAME METAP2, DNPEP, FOLH1 GAA 43/4885MAPT 1189/4885KMT2A 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.